Ipsen S.A. Logo

Ipsen S.A. (IPN)

Euronext

Currency in EUR
142.70
+1.20 (+0.85%)

Closed

Oct 9, 2026

Day's Range

142.30
145.00

52 wk Range

112.70
174.00

Overview - IPN - Ipsen S.A.

Key Statistics

Valuation

Enterprise Value

10.80B

P/E (Trailing)

‪23.18‬

P/E (Forward)

‪10.36‬

PEG Ratio

‪10.36‬

Price / Sales (TTM)

‪2.75‬

Price / Book

‪2.50‬

EV / EBITDA

‪7.23‬

Profitability

Profit Margin

‪11.94%‬

Operating Margin

‪28.48%‬

Return on Assets

‪10.27%‬

Return on Equity

‪11.44%‬

Ownership

Shares Outstanding

82.60M

Float

29.96M

Held by Insiders

‪57.64%‬

Held by Institutions

‪21.87%‬

Price stats

Beta

‪0.31‬

50-Day Avg

‪160.17‬

200-Day Avg

‪154.14‬

Dividends

Payout Ratio

‪25.89%‬

Frequency

Annual

Analyst Consensus

Hold

15 analysts

Average price target

‪€ 167.07‬

News Teaser - IPN - Ipsen S.A.

News & Analysis

View all news

Market Cap - IPN - Ipsen S.A.

Peers - IPN - Ipsen S.A.

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on Euronext.

Profile Summary - IPN - Ipsen S.A.

About

Ipsen S.A. is a French biopharmaceutical company headquartered in Paris, specializing in the development and commercialization of transformative medicines across three core therapeutic areas: oncology, rare diseases, and neuroscience. Founded in 1929 by Dr. Henri Beaufour as a family business, it has evolved over…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees5.53K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.